China to use COVID-19 vaccine by end of year even if trials not completed
The reason for this decision is because of the dwindling number of new coronavirus cases in China.
Follow us on GoogleVial 1 of Box 1. This is the vaccine candidate to be used in Phase 1 clinical trial at the Clinical Biomanufacturing Facility (CBF) in Oxford, Britain, April 2, 2020. Picture taken April 2, 2020(photo credit: SEAN ELIAS/HANDOUT VIA REUTERS)ByAARON REICHFollow us on Google